Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06072443 · ClinicalTrials.gov registry record
AURORA Study-A Transformative Approach to Support PrEP Medication Persistence
A clinical trial of HIV Infections, sponsored by WV Health Right.
- Recruiting
- Registry status
- 105
- Enrollment target
- 1
- Study location
NCT06072443 is a study of HIV Infections that is actively recruiting participants, run by WV Health Right. The registered enrollment target is 105 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06072443, a study of HIV Infections, is actively recruiting participants, sponsored by WV Health Right.
- RECRUITING
- Registry status
- 105 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to test the hypothesis that, compared to oral PrEP, use of CAB-LA in underserved populations in a real-world setting supported by a digital health companion program will be associated with greater medication adherence, persistence, retention-in-care, and improved PROs. Patients in the study will receive current standard care for HIV prevention and be offered enrollment in the digital health companion program. Goal of the study is to evaluate medication adherence and persistence in patients receiving CAB-LA vs oral PrEP and who engage with a digital health companion program.
Conditions Studied
Interventions
- BEHAVIORAL Digital Health Companion (mobile App)
Study Locations (1)
West Virginia
- West Virginia Health Right - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2023-11-30 |
| Est. Completion | 2025-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06072443
The ClinicalTrials.gov registry entry for NCT06072443 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (76% lower). The listed sponsor is WV Health Right, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Digital Health Companion (mobile App) is the first listed.
NCT06072443 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.
Frequently Asked Questions
What is clinical trial NCT06072443 about?
NCT06072443 is a clinical study titled "AURORA Study-A Transformative Approach to Support PrEP Medication Persistence". This study is designed to test the hypothesis that, compared to oral PrEP, use of CAB-LA in underserved populations in a real-world setting supported by a digital health companion program will be associated with greater medication adherence, persistence, retention-in-care, and improved PROs. Patient...
What is the current status of trial NCT06072443?
This trial is currently recruiting. The enrollment target is 105 participants. The study started on 2023-11-30. Estimated completion is 2025-06-30.
What conditions does trial NCT06072443 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT06072443?
The interventions under investigation include: Digital Health Companion (mobile App) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06072443?
This trial is sponsored by WV Health Right, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06072443 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.